Andreas Stahl Selected Research

Fatty Acid Transport Proteins (Fatty Acid Transport Protein)

7/2016	Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation.
8/2008	Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.
8/2006	Protein-mediated fatty acid uptake: novel insights from in vivo models.
4/2006	Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
3/2005	Real-time quantification of fatty acid uptake using a novel fluorescence assay.
3/2004	Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Stahl Research Topics

Disease

18	Retinopathy of Prematurity (Retrolental Fibroplasia) 03/2022 - 01/2009
13	Obesity 01/2022 - 03/2005
11	Pathologic Neovascularization 04/2017 - 01/2009
10	Retinal Neovascularization 03/2022 - 08/2010
8	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2022 - 01/2009
8	Retinal Vein Occlusion 01/2021 - 10/2007
8	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 09/2010
7	Neoplasms (Cancer) 10/2022 - 08/2008
7	Insulin Resistance 01/2022 - 03/2004
6	Inflammation (Inflammations) 01/2021 - 10/2012
6	Retinal Diseases 09/2020 - 04/2009
6	Weight Gain 12/2016 - 12/2010
5	Hypoxia (Hypoxemia) 01/2015 - 10/2007
4	Eye Diseases (Eye Disease) 01/2020 - 11/2011
4	Macular Edema 01/2018 - 10/2007
4	Non-alcoholic Fatty Liver Disease 01/2018 - 08/2008
3	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 09/2014
3	Blindness (Hysterical Blindness) 01/2022 - 05/2012
3	Body Weight (Weight, Body) 01/2022 - 04/2006
3	Wounds and Injuries (Trauma) 09/2020 - 06/2005
3	Choroidal Neovascularization 01/2020 - 04/2009
3	Fatty Liver 02/2014 - 02/2004
3	Type 2 Diabetes Mellitus (MODY) 03/2005 - 02/2004
2	Vascular Diseases (Vascular Disease) 03/2022 - 01/2016
2	Myopia 10/2021 - 10/2015
2	Birth Weight (Birth Weights) 10/2021 - 10/2019
2	Retinal Perforations 01/2021 - 09/2014
2	Ischemia 01/2020 - 10/2013
2	Telangiectasis (Telangiectasia) 01/2020 - 01/2016
2	Hyperoxia 09/2013 - 01/2009
1	Proliferative Vitreoretinopathy 01/2022
1	Diabetes Mellitus 01/2022
1	Myopia 5 10/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2020
1	Vitreous Hemorrhage 06/2020
1	Tics (Tic) 01/2020
1	Metabolic Diseases (Metabolic Disease) 10/2018
1	Bacterial Infections (Bacterial Infection) 11/2017
1	Infections 11/2017
1	Glucose Intolerance 12/2016
1	Liver Diseases (Liver Disease) 12/2016
1	Central Serous Chorioretinopathy 11/2016

Drug/Important Bio-Agent (IBA)

22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 10/2007
19	Retinaldehyde (Retinal)IBA 03/2022 - 04/2009
17	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 05/2003
13	Oxygen (Dioxygen)IBA 01/2020 - 01/2009
11	LipidsIBA 01/2018 - 05/2003
9	Insulin (Novolin)FDA Link 01/2022 - 02/2004
8	Ranibizumab (Lucentis)FDA Link 03/2022 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2004
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2005
6	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 07/2016 - 03/2004
5	RNA (Ribonucleic Acid)IBA 10/2022 - 03/2013
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2016 - 02/2011
4	Triglycerides (Triacylglycerol)IBA 01/2016 - 06/2005
3	Bevacizumab (Avastin)FDA Link 01/2010 - 10/2007
2	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 01/2016
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2020 - 01/2016
2	CopperIBA 10/2018 - 12/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018 - 08/2015
2	MetalsIBA 11/2017 - 12/2016
2	Dietary Fats (Dietary Fat)IBA 01/2016 - 02/2014
2	CytokinesIBA 08/2015 - 10/2012
2	VLDL LipoproteinsIBA 08/2015 - 04/2011
2	Biological ProductsIBA 08/2015 - 08/2008
2	AdiponectinIBA 10/2014 - 03/2004
2	PPAR gammaIBA 01/2013 - 08/2010
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 11/2012
2	Bile Acids and Salts (Bile Acids)IBA 10/2012 - 04/2006
1	TOR Serine-Threonine KinasesIBA 10/2022
1	cabozantinibIBA 10/2022
1	N-lactoyl-phenylalanineIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Nicotine FDA Link 07/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2020
1	tdTomatoIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	Bone Morphogenetic Protein 4IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	IronIBA 11/2017
1	N-acetyltryptophanamide (NATA)IBA 01/2017
1	LuciferasesIBA 12/2016
1	Eplerenone (Inspra)FDA LinkGeneric 11/2016
1	HydrogelsIBA 05/2016

Therapy/Procedure

10	Therapeutics 03/2022 - 08/2008
7	Lasers (Laser) 03/2022 - 01/2013
5	Laser Therapy (Surgery, Laser) 01/2022 - 10/2015
3	Aftercare (After-Treatment) 01/2022 - 01/2019
3	Intravitreal Injections 10/2021 - 01/2020
2	Light Coagulation 03/2022 - 12/2019
2	Vitrectomy 01/2021 - 09/2014
2	Injections 01/2017 - 04/2009
1	Immunotherapy 10/2022
1	Reoperation 01/2022
1	Retreatment 10/2019
1	Corneal Transplantation (Keratoplasty) 10/2018